Effects of roflumilast on cognition in healthy adults: a behaviour-EEG study - Roflumilast and cognition

Maastricht University Medical Center0 个研究点目标入组 22 人开始时间: 2011年6月1日最近更新: 2023年12月19日

适应症

试验速览

暂无简介。

•18 to 35 years of age
•Healthy (i.e. absence of all exclusion criteria), normal static binocular acuity (corrected or uncorrected),
•Body mass index between 18.5 and 30
•Willingness to sign an informed consent.
•Positive evaluation on the memory screening
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 22
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Volunteers who suffer from, or have a history of cardiac, hepatic, renal, pulmonary, neurological, gastrointestinal, haematological, or psychiatric illness, will be excluded. Those volunteers who have a first-degree relative with a psychiatric disorder or a history of depressive disorder with or without suicidal risk will be excluded as well. Other exclusion criteria are excessive drinking (>20 glasses of alcohol containing beverages a week), pregnancy or lactation, use of chronic medication other than oral contraceptives, use of recreational drugs from 2 weeks before until the end of the experiment, smoking, orthostatic hypotension, lactose intolerance, and any sensory or motor deficits which could reasonably be expected to affect test performance.

发起方